Citigroup
IPSC icon

Citigroup’s Century Therapeutics IPSC Stock Holding History

Citigroup’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$1 – 6155
2025
Q4 		$1 Sell
1
-2,209
-100% -$1.35K ﹤0.01% 5974
2025
Q3 		$1.1K Sell
2,210
-13,763
-86% -$7.42K ﹤0.01% 5612
2025
Q2 		$8.92K Sell
15,973
-16,886
-51% -$9.06K ﹤0.01% 5207
2025
Q1 		$15.6K Sell
32,859
-3,235
-9% -$2.43K ﹤0.01% 5129
2024
Q4 		$36.5K Buy
36,094
+2,007
+6% +$2.73K ﹤0.01% 5164
2024
Q3 		$58.3K Buy
34,087
+23,572
+224% +$46.2K ﹤0.01% 4976
2024
Q2 		$26.8K Buy
10,515
+5,919
+129% +$18.7K ﹤0.01% 4909
2024
Q1 		$19.2K Buy
4,596
+1,078
+31% +$4.56K ﹤0.01% 5040
2023
Q4 		$11.7K Buy
3,518
+2,764
+367% +$5.04K ﹤0.01% 5154
2023
Q3 		$1.51K Sell
754
-7,585
-91% -$20.2K ﹤0.01% 5025
2023
Q2 		$26.4K Buy
8,339
+7,668
+1,143% +$24.7K ﹤0.01% 4888
2023
Q1 		$2.33K Sell
671
-216
-24% -$949 ﹤0.01% 5075
2022
Q4 		$4.55K Sell
887
-120
-12% -$1.13K ﹤0.01% 5053
2022
Q3 		$10K Sell
1,007
-1,165
-54% -$12.3K ﹤0.01% 4991
2022
Q2 		$18K Buy
2,172
+329
+18% +$3.23K ﹤0.01% 5061
2022
Q1 		$23K Sell
1,843
-2,891
-61% -$38.3K ﹤0.01% 5077
2021
Q4 		$75K Buy
4,734
+3,399
+255% +$63.9K ﹤0.01% 4878
2021
Q3 		$34K Buy
+1,335
New +$36.1K ﹤0.01% 4963

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Citigroup's IPSC Position: Q1 2026 in Review

Citigroup sold out of Century Therapeutics (IPSC) in Q1 2026, closing a stake of 1 share — an estimated $1 sold.

Citigroup first reported a position in IPSC in Q3 2021 and held it in 18 quarters. The position peaked at $75K in Q4 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Citigroup reported no remaining Century Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 1 Century Therapeutics share in Q1 2026, an estimated $1.
  • Citigroup first reported a position in Century Therapeutics in Q3 2021 and held it in 18 quarters.
  • Citigroup's Century Therapeutics position peaked at $75K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.